Dr. Bratman is Scientist at Princess Margaret Cancer Centre Research Institute and Assistant Professor of Radiation Oncology & Medical Biophysics at the University of Toronto. He received his MD and PhD from Columbia University in 2009 followed by postdoctoral research and clinical training at Stanford Cancer Institute. Since joining The Princess Margaret in 2014, Dr. Bratman has served as Staff Radiation Oncologist within the Wharton Head and Neck Centre and has led basic, translational, and clinical research studies on head and neck cancer and circulating biomarkers.
Dr. Bratman's primary research focus is on improving outcomes for patients with head and neck cancer and other cancers through optimized detection and personalized treatments. His laboratory is currently developing and validating blood-based biomarkers for detecting and monitoring the presence of cancer.
Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG.
Blood. 2018 Nov 16;:
Nature. 2018 Nov 14;:
Eat Weight Disord. 2018 Nov 09;:
Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma.
Cell Rep. 2018 Oct 30;25(5):1318-1331.e4
A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy.
Radiother Oncol. 2018 Sep 29;:
Predictors of early recurrence prior to planned post-operative radiation therapy for oral cavity squamous cell carcinoma and outcomes following salvage intensified radiation therapy.
Int J Radiat Oncol Biol Phys. 2018 Sep 20;:
Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2018 Oct 01;102(2):340-352
Radiologic-Pathologic Correlation of Tumor Thickness and Its Prognostic Importance in Squamous Cell Carcinoma of the Oral Cavity: Implications for the Eighth Edition Tumor, Node, Metastasis Classification.
AJNR Am J Neuroradiol. 2018 Aug 30;:
Nature. 2018 Jul 09;:
Prevalence, prognosis, and treatment implications of retropharyngeal nodes in unknown primary head and neck carcinoma.
Oral Oncol. 2018 Jul;82:162-167
Scientist, Princess Margaret Cancer Centre
Assistant Professor, Department of Medical Biophysics, University of Toronto
Assistant Professor, Department of Radiation Oncology, University of Toronto